Regulation

Helmerich & Payne, Inc. Announces Upsize and Pricing of $550 Million Offering of 2.900% Senior Notes due 2031

Monday, September 27, 2021 - 11:49pm

The offering size was increased from the previously announced offering size of $500 million in aggregate principal amount.

Key Points: 
  • The offering size was increased from the previously announced offering size of $500 million in aggregate principal amount.
  • The Company intends to use the net proceeds from the Offering, plus cash on hand, to redeem and retire all of the Companys outstanding 4.65% Senior Notes due 2025 (the 2025 Notes).
  • As of the date of this press release, $487.1 million aggregate principal amount of the 2025 Notes are outstanding.
  • The Offering is not conditioned on the redemption of the 2025 Notes.

PGTI Announces Closing of $575 Million of 4.375% Senior Notes due 2029

Monday, September 27, 2021 - 9:30pm

The offering was exempt from the registration requirements of the Securities Act of 1933 (the Securities Act).

Key Points: 
  • The offering was exempt from the registration requirements of the Securities Act of 1933 (the Securities Act).
  • The Anlin Acquisition was announced on September 2, 2021, and is expected to close in the fourth quarter of 2021.
  • Forward-looking statements are statements other than historical fact, and include statements relating to the offering of Notes, including the use of proceeds therefrom.
  • These "forwardlooking statements" involve risks and uncertainties which could cause actual results to differ materially from those contained in the forward-looking statements.

Gap Inc. Announces Closing of $1.5 Billion Senior Notes Offering

Monday, September 27, 2021 - 9:15pm

The Gap, Inc. (NYSE: GPS) (Gap Inc. or the Company) today announced it has closed its previously announced offering of $1.5 billion of senior notes (the Notes), consisting of $750 million aggregate principal amount of the Companys 3.625% Senior Notes due 2029 and $750 million aggregate principal amount of the Companys 3.875% Senior Notes due 2031.

Key Points: 
  • The Gap, Inc. (NYSE: GPS) (Gap Inc. or the Company) today announced it has closed its previously announced offering of $1.5 billion of senior notes (the Notes), consisting of $750 million aggregate principal amount of the Companys 3.625% Senior Notes due 2029 and $750 million aggregate principal amount of the Companys 3.875% Senior Notes due 2031.
  • Nothing contained herein shall constitute an offer to sell or the solicitation of an offer to buy any security.
  • Gap Inc., a collection of purpose-led lifestyle brands, is the largest American specialty apparel company offering clothing, accessories, and personal care products for men, women, and children under the Old Navy, Gap, Banana Republic, and Athleta brands.
  • Gap Inc. products are available for purchase worldwide through company-operated stores, franchise stores, and e-commerce sites.

Acadia Realty Trust to Announce Third Quarter 2021 Earnings on October 26, 2021

Monday, September 27, 2021 - 9:15pm

Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual Core Portfolio and Fund operating platforms and its disciplined, location-driven investment strategy.

Key Points: 
  • Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual Core Portfolio and Fund operating platforms and its disciplined, location-driven investment strategy.
  • Accordingly, investors should monitor the Investors page, in addition to following the Companys press releases, SEC filings, public conference calls, presentations and webcasts.
  • The information contained on, or that may be accessed through, the website is not incorporated by reference into, and is not a part of, this document.
  • Any forward-looking statements in this press release speak only as of the date hereof.

Murphy & McGonigle Names New Office Managing Partners for New York, Virginia

Monday, September 27, 2021 - 9:28pm

NEW YORK, Sept. 27, 2021 /PRNewswire/ -- Financial services law firm Murphy & McGonigle announced today the appointment of two attorneys as new Office Managing Partners (OMP) at the Firm.

Key Points: 
  • NEW YORK, Sept. 27, 2021 /PRNewswire/ -- Financial services law firm Murphy & McGonigle announced today the appointment of two attorneys as new Office Managing Partners (OMP) at the Firm.
  • Katherine McGrail, litigation shareholder and the Chief Diversity, Equity & Inclusion Officer, becomes the new Office Managing Partner of the Virginia office, and litigation shareholder Andrew Melnick will serve as Office Managing Partner of the firm's headquarters New York office.
  • Both attorneys will also serve on the Firm's Executive Committee, along with Elizabeth Lan Davis, Chair of Murphy & McGonigle; Tom McGonigle, Office Managing Partner of the Washington, DC office; and New York shareholder Leonard Amoruso.
  • Murphy & McGonigle operates in New York, Washington, DC, Virginia, Chicago and San Francisco.

Cenovus and Headwater announce bought deal secondary offering of Headwater common shares worth approximately $114 million

Monday, September 27, 2021 - 8:24pm

CALGARY, Alberta, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) (“Cenovus” or the “Selling Shareholder”) and Headwater Exploration Inc. (TSX: HWX) (“Headwater” or the “Company”) announced today that they have entered into an agreement with Peters & Co. Limited and BMO Capital Markets (the “Lead Underwriters”), on behalf of a syndicate of underwriters (together with the Lead Underwriters, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, from Cenovus, through its wholly owned subsidiary, Cenovus Marten Hills Partnership (the “Partnership”), 25,000,000 common shares of the Company (the “Common Shares”) at a price of $4.55 per Common Share (the “Offering Price”) for total gross proceeds to the Selling Shareholder of $113,750,000 (the “Offering”). The Selling Shareholder has granted the Underwriters an option to purchase an additional 15% of the Common Shares issued under the Offering (3,750,000 Common Shares) at the Offering Price exercisable to cover over-allotments and for market stabilization purposes in whole or in part at any time until 30 days after the closing. The Company will not receive any of the proceeds from the Offering or the over-allotment option, if exercised.

Key Points: 
  • Cenovus currently holds, indirectly through the Partnership, 50,000,000 Common Shares, representing approximately 24.7% of the issued and outstanding Common Shares and 15,000,000 purchase warrants exercisable at $2.00 per Common Share until December 2, 2023.
  • Following the closing of the Offering, Cenovus will indirectly hold 25,000,000 Common Shares (21,250,000 Common Shares assuming full exercise of the over-allotment option), representing approximately 12.3% of the issued and outstanding Common Shares (10.5% assuming full exercise of the over-allotment option) and 15,000,000 warrants to purchase Common Shares.
  • Assuming exercise of the warrants held by Cenovus, following closing of the Offering, Cenovus would indirectly hold 40,000,000 Common Shares (36,250,000 Common Shares assuming full exercise of the over-allotment option), representing approximately 18.4% of the issued and outstanding Common Shares (16.7% assuming full exercise of the over-allotment option).
  • Cenovus is selling the Common Shares as part of its plan to reduce net debt levels towards its $10 billion interim target and accelerate shareholder returns.

Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021

Monday, September 27, 2021 - 9:01pm

GAITHERSBURG, Md., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report the results from its 12-week Phase 1 clinical trial of ALT-801 in overweight and obese subjects in a pre-market press release and webcast to be held on Tuesday, September 28, 2021.

Key Points: 
  • GAITHERSBURG, Md., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report the results from its 12-week Phase 1 clinical trial of ALT-801 in overweight and obese subjects in a pre-market press release and webcast to be held on Tuesday, September 28, 2021.
  • Altimmune management will host a conference call and webcast with a slide presentation beginning at 8:30 am E.T.
  • Following the conclusion of the call, the webcast will be available for replay on the Investor Relations page of the Companys website at www.altimmune.com.
  • The company has used, and intends to continue to use, the IR portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.

Vinyl Institute Welcomes Christina Xydis as Director of Regulatory & Technical Affairs

Monday, September 27, 2021 - 8:00pm

WASHINGTON, Sept. 27, 2021 /PRNewswire-PRWeb/ --The Vinyl Institute (VI), the U.S. trade association representing manufacturers of vinyl, vinyl chloride monomer (VCM), additives, and modifiers, announced today that Christina Xydis has joined the organization as Director of Regulatory & Technical Affairs.

Key Points: 
  • WASHINGTON, Sept. 27, 2021 /PRNewswire-PRWeb/ --The Vinyl Institute (VI), the U.S. trade association representing manufacturers of vinyl, vinyl chloride monomer (VCM), additives, and modifiers, announced today that Christina Xydis has joined the organization as Director of Regulatory & Technical Affairs.
  • Xydis has more than 14 years of regulatory and environmental, health & safety (EHS) experience in the nuclear and biosciences industries.
  • Prior to her position with the Vinyl Institute, she worked in a variety of positions for Exelon, a national leading energy provider.
  • The Vinyl Institute (VI), founded in 1982, is a U.S. trade association representing the leading manufacturers of vinyl, vinyl chloride monomer, vinyl additives, and modifiers.

Discovery Divests Non-Core Exploration Property

Monday, September 27, 2021 - 3:55pm

In addition, subject to the exercise of the option to acquire the Property pursuant to the Agreement, Discovery would retain a 1.5% net smelter returns royalty payable upon the commercial production of the Property in accordance with the terms set out in the Agreement and pursuant to a separate royalty agreement between Discovery and Monumentals Mexican subsidiaries.

Key Points: 
  • In addition, subject to the exercise of the option to acquire the Property pursuant to the Agreement, Discovery would retain a 1.5% net smelter returns royalty payable upon the commercial production of the Property in accordance with the terms set out in the Agreement and pursuant to a separate royalty agreement between Discovery and Monumentals Mexican subsidiaries.
  • The divestiture of the Property is consistent with the Companys strategy of streamlining its property portfolio in order to focus on its flagship Cordero project in Chihuahua, Mexico.
  • The transaction also provides Discovery with investment exposure to an early-stage exploration property with known showings of rare earth elements.
  • Discovery does not assume any obligation to update any forward-looking statements except as required under applicable laws.

Nabati Foods Files Final Prospectus and Receives CSE Conditional Approval

Monday, September 27, 2021 - 4:00pm

Nabati is also pleased to announce that it has received conditional approval to list its common shares (the Common Shares) on the Canadian Securities Exchange (CSE).

Key Points: 
  • Nabati is also pleased to announce that it has received conditional approval to list its common shares (the Common Shares) on the Canadian Securities Exchange (CSE).
  • A copy of the Final Prospectus can be found on the Companys SEDAR profile at www.sedar.com .
  • Nabati expects to complete its listing and to have the Common Shares commence trading on the CSE under the symbol MEAL, subject to the Company fulfilling all CSE listing requirements.
  • Nabati, through its wholly-owned subsidiary, Nabati Foods Inc., is a food technology company offering whole, natural, plant-based, gluten and soy-free foods for health-conscious consumers.